Home/Filings/4/0001415889-12-001278
4//SEC Filing

FLEMING WILLIAM H 4

Accession 0001415889-12-001278

CIK 0000820608other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 12:13 PM ET

Size

12.7 KB

Accession

0001415889-12-001278

Insider Transaction Report

Form 4
Period: 2012-05-25
FLEMING WILLIAM H
DirectorSee Remarks
Transactions
  • Other

    Common Stock

    2012-05-25$0.06/sh+300,000$18,0001,263,034 total
Holdings
  • Common Stock Warrant

    Exercise: $0.50Exp: 2014-07-24Common Stock (150,000 underlying)
    150,000
  • Common Stock

    (indirect: By Brother)
    1,000
  • Non Qualified Stock Options

    Exercise: $0.50Exp: 2014-07-30Common Stock (125,000 underlying)
    125,000
  • Incentive Stock Options

    Exercise: $1.60Exp: 2016-04-30Common Stock (100,000 underlying)
    100,000
  • Common Stock Warrant

    Exercise: $0.31From: 2009-01-15Exp: 2014-01-15Common Stock (110,000 underlying)
    110,000
  • Incentive Stock Options

    Exercise: $0.85Exp: 2017-10-08Common Stock (50,000 underlying)
    50,000
Footnotes (6)
  • [F1]Common stock issued in consideration for services rendered to QuantRx Biomedical Corporation.
  • [F2]Price based on fair market value on the day of issuance.
  • [F3]The options were granted on July 24, 2009 and fully vested with achievement of development milestone in November 2009.
  • [F4]The options were granted on July 30, 2009 and half vested with achievement of development milestone in November 2009; remaining half vest upon achievement of development milestone which, as of August 9, 2012, has not yet been achieved.
  • [F5]The options were granted October 8, 2007 and fully vested on October 8, 2008.
  • [F6]The options were granted on April 3, 2006 and vest upon reaching negotiated sales of $10M.

Issuer

QUANTRX BIOMEDICAL CORP

CIK 0000820608

Entity typeother

Related Parties

1
  • filerCIK 0001029316

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 12:13 PM ET
Size
12.7 KB